Accéder au contenu
Merck
Toutes les photos(1)

Key Documents

View All Documentation

Y0000672

Iohexol for peak identification

European Pharmacopoeia (EP) Reference Standard

Synonyme(s) :

5-[N-(2,3-Dihydroxypropyl)acetamido]-2,4,6-triiodo-N,N′-bis(2,3-dihydroxypropyl)isophthalamide

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Toutes les photos(1)

About This Item

Formule empirique (notation de Hill):
C19H26I3N3O9
Numéro CAS:
66108-95-0
Poids moléculaire :
821.14
Numéro Beilstein :
2406632
Numéro MDL:
MFCD00077732
Code UNSPSC :
41116107
ID de substance PubChem :
329831086
Nomenclature NACRES :
NA.24

Qualité

pharmaceutical primary standard

Famille d'API

iohexol

Fabricant/nom de marque

EDQM

Application(s)

pharmaceutical (small molecule)

Format

neat

Température de stockage

2-8°C

Chaîne SMILES 

IC1=C(C(NCC(O)CO)=O)C(I)=C(C(NCC(CO)O)=O)C(I)=C1N(CC(CO)O)C(C)=O

InChI

1S/C19H26I3N3O9/c1-8(29)25(4-11(32)7-28)17-15(21)12(18(33)23-2-9(30)5-26)14(20)13(16(17)22)19(34)24-3-10(31)6-27/h9-11,26-28,30-32H,2-7H2,1H3,(H,23,33)(H,24,34)

Clé InChI

NTHXOOBQLCIOLC-UHFFFAOYSA-N

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Description générale

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Iohexol for peak identification EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Conditionnement

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Autres remarques

Sales restrictions may apply.

Produit(s) apparenté(s)

Réf. du produit
Description
Tarif

1344622

Iohexol Related Compound A, United States Pharmacopeia (USP) Reference Standard

I0320810

Iohexol impurity A, European Pharmacopoeia (EP) Reference Standard

I0320800

Iohexol, European Pharmacopoeia (EP) Reference Standard

I0320820

Iohexol impurity J, European Pharmacopoeia (EP) Reference Standard

1344600

Iohexol, United States Pharmacopeia (USP) Reference Standard

1344644

Iohexol Related Compound B, United States Pharmacopeia (USP) Reference Standard

1344666

Iohexol Related Compound C, United States Pharmacopeia (USP) Reference Standard

PHR1931

Iohexol, Pharmaceutical Secondary Standard; Certified Reference Material

Code de la classe de stockage

11 - Combustible Solids

Classe de danger pour l'eau (WGK)

WGK 1

Point d'éclair (°F)

Not applicable

Point d'éclair (°C)

Not applicable

Faites votre choix parmi les versions les plus récentes :

Certificats d'analyse (COA)

Lot/Batch Number

Désolés, nous n'avons pas de COA pour ce produit disponible en ligne pour le moment.

Si vous avez besoin d'assistance, veuillez contacter Service Clients

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

N J Bureau et al.
AJNR. American journal of neuroradiology, 35(8), 1467-1474 (2014-05-31)
Transforaminal corticosteroid injections can be performed in the management of cervical radiculopathy but carry the risk of catastrophic complications. This study compares the efficacy of transforaminal and facet corticosteroid injections at 4 weeks' follow-up. We randomly assigned 56 subjects to
E Van de Kelft et al.
Neurosurgery, 28(4), 570-574 (1991-04-01)
Intracranial hemorrhage is an uncommon complication of dural puncture. In most instances, hematomas are subdural; they may be unilateral or bilateral. Rarely are intraparenchymal cerebral hemorrhages related to dural puncture. This report describes a delayed occurrence of bilateral intraparenchymal hemorrhages
Catrina Hansen et al.
AJR. American journal of roentgenology, 202(4), W357-W364 (2014-03-26)
The purpose of this study was to evaluate the diagnostic performance of a dedicated dual-source dual-energy MDCT (DECT) protocol for the detection of urothelial tumors. A DECT protocol including furosemide and split-bolus contrast injection was used in 69 consecutive patients
Marlijne E Ikink et al.
European radiology, 24(10), 2649-2657 (2014-08-15)
To compare the effectiveness of magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU) with that of uterine artery embolisation (UAE) for treatment of uterine fibroids. Between January 2010 and January 2013, 51 women with symptomatic uterine fibroids underwent MR-HIFU. Follow-up and MR imaging
Robert P Jones et al.
AJR. American journal of roentgenology, 204(3), 519-526 (2015-02-26)
OBJECTIVE. The purpose of this article is to evaluate the hypothesis that Alvarado scores of 3 or lower identify adult patients who are unlikely to benefit from CT after appendiceal ultrasound fails to show the appendix and is otherwise normal.
Afficher tous les articles scientifiques apparentés

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique